Acadia Healthcare (NASDAQ:ACHC) is scheduled to be announcing its earnings results after the market closes on Tuesday, May 1st. Analysts expect the company to announce earnings of $0.48 per share for the quarter. Acadia Healthcare has set its Q1 guidance at $0.47-0.49 EPS and its FY18 guidance at $2.42-2.48 EPS.
Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, February 21st. The company reported $0.61 EPS for the quarter, beating the Zacks’ consensus estimate of $0.54 by $0.07. Acadia Healthcare had a net margin of 6.92% and a return on equity of 8.16%. The company had revenue of $724.50 million for the quarter, compared to analyst estimates of $713.20 million. During the same quarter last year, the firm posted $0.59 earnings per share. The company’s quarterly revenue was up 3.1% compared to the same quarter last year. On average, analysts expect Acadia Healthcare to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.
NASDAQ:ACHC opened at $37.76 on Tuesday. Acadia Healthcare has a 12 month low of $26.92 and a 12 month high of $54.34. The company has a market capitalization of $3,352.61, a PE ratio of 16.44, a PEG ratio of 1.24 and a beta of 0.63. The company has a debt-to-equity ratio of 1.25, a quick ratio of 1.25 and a current ratio of 1.25.
ACHC has been the topic of several research analyst reports. Credit Suisse Group restated a “neutral” rating and issued a $40.00 price objective (up previously from $35.00) on shares of Acadia Healthcare in a research note on Thursday, February 22nd. Wells Fargo initiated coverage on shares of Acadia Healthcare in a research note on Tuesday, January 30th. They issued an “outperform” rating and a $41.00 price objective on the stock. Royal Bank of Canada restated a “buy” rating and issued a $45.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, February 27th. BidaskClub downgraded shares of Acadia Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, April 17th. Finally, Cantor Fitzgerald upgraded shares of Acadia Healthcare from a “neutral” rating to an “overweight” rating in a research note on Sunday, February 25th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and twelve have issued a buy rating to the company. Acadia Healthcare currently has an average rating of “Buy” and an average price target of $44.50.
WARNING: “Acadia Healthcare (ACHC) to Release Quarterly Earnings on Tuesday” was reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://stocknewstimes.com/2018/04/24/acadia-healthcare-achc-to-release-quarterly-earnings-on-tuesday.html.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.